Drugs News and Research

RSS

New drug candidate reverses obesity in mice by transforming liver metabolism

A mitochondrial transcription inhibitor (IMT) shifted metabolism in high-fat diet mice toward fatty acid oxidation, leading to weight loss, reduced liver fat, and improved glucose tolerance.

1 May 2024

Study uncovers molecular mechanism linking nonsense-mediated RNA decay to microcephaly

Nonsense-mediated RNA decay, or NMD, is an evolutionarily conserved molecular mechanism in which potentially defective messenger RNAs, or mRNAs (genetic material that instructs the body on how to make proteins), are degraded.

1 May 2024

Psilocybin found to be more effective than controls for treating depression symptoms

Psilocybin - the active ingredient in "magic" mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published by The BMJ today.

1 May 2024

Study investigates senescent phenotypes of human corneal endothelial cells upon UV-A exposure

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 8, entitled, "Senescent characteristics of human corneal endothelial cells upon ultraviolet-A exposure."

30 Apr 2024

New monoclonal antibody vaccine slashes malaria risk in children

A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and 77%, respectively.

30 Apr 2024

Gut bacteria and urinary infections linked, offering new angles for treatment

A study in eClinicalMedicine explores the relationship between gut microbiota, urinary tract colonization, and recurrent urinary tract infections (rUTI), suggesting the cross-habitation of uropathogenic E. coli as a significant mechanism in rUTI recurrence.

30 Apr 2024

New approach to inhibit strep’s DNA-cleaving enzymes

An entirely new approach to inhibiting DNA-cleaving enzymes works through the aggregation of an otherwise non-toxic molecule.

30 Apr 2024

Specific class of drugs can reverse diet-induced obesity, fatty liver and diabetes in mice

Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' powerhouses, the mitochondria.

30 Apr 2024

Fentanyl inhalation linked to irreversible brain damage

Inhaling the synthetic opioid fentanyl may cause potentially irreversible brain damage (toxic leukoencephalopathy), warn doctors in the journal BMJ Case Reports, after treating a middle aged man found unresponsive in his hotel room after snorting the drug.

29 Apr 2024

Exhaled breath may be a promising avenue for antibiotic monitoring

Exhaled breath may be very promising alternative to blood for the therapeutic monitoring of antibiotics, the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.

29 Apr 2024

New Kaposi sarcoma mouse model could be key to drug development

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat the disease.

29 Apr 2024

Study reveals brown fat's built-in mechanism and potential obesity treatment

Brown fat, also known as brown adipose tissue (BAT), is a type of fat in our bodies that's different from the white fat around our belly and thighs that we are more familiar with.

29 Apr 2024

Ancient grains show promise for type 2 diabetes

A meta-analysis in the journal Nutrition, Metabolism and Cardiovascular Diseases finds that ancient grains like oats, brown rice, and millet may improve lipid profiles in type 2 diabetes patients, but variations in study designs call for further research to confirm these benefits.

29 Apr 2024

Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug

Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation and protect brain cells in Parkinson’s. NLRP3 is a protein that plays a role in regulating a number of inflammatory processes that are believed to contribute to the damage to brain cells that underlies Parkinson’s.

27 Apr 2024

Harnessing immune enhancement to combat drug-resistant tuberculosis

Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease.

26 Apr 2024

Blood test predicts knee osteoarthritis eight years before tell-tale signs of the disease

A blood test successfully predicted knee osteoarthritis at least eight years before tell-tale signs of the disease appeared on x-rays, Duke Health researchers report.

26 Apr 2024

Japanese researchers test cardiac spheroids for heart regeneration in monkeys

Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function.

26 Apr 2024

Immune cells play a bigger role in high blood pressure than previously thought, opening doors for new treatments

A review in Nature Reviews Nephrology presents the association between immune cells and the development of hypertension, suggesting potential new therapeutic targets to mitigate the disease by managing inflammation.

26 Apr 2024

Study: Antibiotic use in moderate COVID-19 linked to clinical deterioration

Antibiotic treatment of adults hospitalized with moderate COVID-19 is associated with clinical deterioration, despite the drugs being given to over 40% of patients, according to new research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April)

25 Apr 2024

Synthetic nanomaterial could be an effective tool for treating neurodegenerative diseases

A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer's and other neurodegenerative diseases.

25 Apr 2024

1
2
3
4
...
2775
Next

Drugs News and Research

New drug candidate reverses obesity in mice by transforming liver metabolism

Study uncovers molecular mechanism linking nonsense-mediated RNA decay to microcephaly

Psilocybin found to be more effective than controls for treating depression symptoms

Study investigates senescent phenotypes of human corneal endothelial cells upon UV-A exposure

New monoclonal antibody vaccine slashes malaria risk in children

Gut bacteria and urinary infections linked, offering new angles for treatment

New approach to inhibit strep’s DNA-cleaving enzymes

Specific class of drugs can reverse diet-induced obesity, fatty liver and diabetes in mice

Fentanyl inhalation linked to irreversible brain damage

Exhaled breath may be a promising avenue for antibiotic monitoring

New Kaposi sarcoma mouse model could be key to drug development

Study reveals brown fat's built-in mechanism and potential obesity treatment

Ancient grains show promise for type 2 diabetes

Parkinson’s UK invests £2.1 million in Neumora Therapeutics for preclinical testing of new Parkinson’s drug

Harnessing immune enhancement to combat drug-resistant tuberculosis

Blood test predicts knee osteoarthritis eight years before tell-tale signs of the disease

Japanese researchers test cardiac spheroids for heart regeneration in monkeys

Immune cells play a bigger role in high blood pressure than previously thought, opening doors for new treatments

Study: Antibiotic use in moderate COVID-19 linked to clinical deterioration

Synthetic nanomaterial could be an effective tool for treating neurodegenerative diseases

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News